Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin

Por Chen, Wei-Ching, Hsu, Hui-Ping, Li, Chung-Yen, Yang, Ya-Ju, Hung, Yu-Hsuan, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Ming-Derg
Publicado no Int J Oncol (2016)

MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer

Por Cho, Chien-Yu, Lee, Kuo-Ting, Chen, Wei-Ching, Wang, Chih-Yang, Chang, Yung-Sheng, Huang, Hau-Lun, Hsu, Hui-Ping, Yen, Meng-Chi, Lai, Ming-Zong, Lai, Ming-Derg
Publicado no Oncotarget (2016)

Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells

Por Hung, Yu-Hsuan, Huang, Hau-Lun, Chen, Wei-Ching, Yen, Meng-Chi, Cho, Chien-Yu, Weng, Tzu-Yang, Wang, Chih-Yang, Chen, Yi-Ling, Chen, Li-Tzong, Lai, Ming-Derg
Publicado no Oncol Rep (2017)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

Por Chen, Wei-Ching, Chang, Yung-Sheng, Hsu, Hui-Ping, Yen, Meng-Chi, Huang, Hau-Lun, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Po-Ting, Chen, Ching-Shih, Lin, Yih-Jyh, Lai, Ming-Derg
Publicado no Oncotarget (2015)